reactive, a non-treponemal test, such as the RPR, is performed and an endpoint titer is determined if the test is reactive. In the case of a nonreactive non-treponemal test, the Centers for Disease Control and Prevention (CDC) recommends that the sera be analyzed by the T pallidum passive particle agglutination test (TP-PA). 3 A reactive TP-PA usually indicates either a past, treated, or late/latent syphilis infection, while a nonreactive TP-PA would indicate a false-reactive treponemal screen. However, since about 30% of patients with early syphilis will have a nonreactive non-treponemal test, 2 some reactive TP-PA results may represent early syphilis, given that treponemal antibodies are detected a little before non-treponemal antibodies are detected.
The false-reactive rate of the treponemal EIA/CLIA screening assays varies based on the prevalence of syphilis in the population being tested, with low prevalence areas giving the highest false positivity rates. South Carolina is considered a moderately high prevalence area for syphilis infections. The rate of primary and secondary syphilis was 5.7 per 100 000 in 2013. The state ranks 11th in rates of syphilis among 50 states. 5 A number of studies have demonstrated a high percentage of falsely reactive tests using EIA/CLIA methods in the reverse syphilis screening algorithm. 3, [5] [6] [7] Reverse algorithm screening often results in a higher false-reactivity rate than traditional testing does in areas with both a low and high prevalence of syphilis. 3, 5 In our previous study of the BioPlex IgG screen, the overall false-reactive rate was 1.0%. 8 The BioPlex IgG screen false-reactivity rate was more consistent with rates seen in low prevalence populations. 8 Our institution has been using the BioPlex IgG screen for our syphilis screening assay based its automation, high throughput, and ease of use. However, other syphilis screening assays are available, such as the Lumipulse G TP-N chemiluminescent immunoassay, 9 TrepSure EIA, 6 and LIASON CIA, 9 that detect both a treponemal This study is an analysis of effect on accuracy with the addition of the detection of IgM treponemal antibodies in the IgG/IgM screen compared to the IgG screen along with an analysis of the automated RPR compared with the traditional RPR assay. 
| MATERIAL S AND ME THODS

| Study samples
| Treponemal screening test
All samples were tested using both the BioPlex 2200 syphilis IgG and 
| Reflex to non-treponemal tests
| Treponemal confirmatory tests
All samples that were IgG or IgG/IgM BioPlex reactive, but RPR nonreactive or discrepant between the two RPR methodologies were further tested by Serodia TP-PA (Fujiribio Diagnostics, Inc, Seguin, TX), a gelatin particle agglutination assay. This assay was performed according to the manufacturers' protocol. The results were read as nonreactive, borderline, or reactive.
| Statistical analysis
Comparisons of the IgG BioPlex screen algorithm with the IgG/IgM
BioPlex screen algorithm and the tradition RPR with the BioPlex RPR were analyzed using a Yates' corrected chi-square test to determine the overall agreement, clinical sensitivity, clinical specificity, and 95% confidence intervals for sensitivity and specificity. 10 Other statistical calculations were performed using an Excel spreadsheet (Microsoft Corp., Redmond, WA). 
| RE SULTS
| Reverse algorithm screening results
| False-reactive samples on IgG/IgM BioPlex screen or IgG BioPlex screen
The false-reactive screens for the IgG/IgM BioPlex screen and IgG
BioPlex screen were from patients who were either screened prenatally, screened for pretransplant workup, or were patients at risk for a STD.
There were five samples that were reactive only by the IgG screen and found nonreactive by TP-PA. Three samples were from patients undergoing prenatal screen, one patient had a rash on soles of feet and another was a high-risk patient undergoing an STD screen.
There were two samples that were reactive only by the Syphilis Total (IgG/IgM) screen. One patient was undergoing a pretransplant screen and another was undergoing routine STD screening.
| Samples discrepant on the traditional and automated RPR
There were 10 samples that were discrepant on the traditional and automated RPR (Lower half of Table 3 ). All except one sample were from patients who were treated in the past for syphilis. 
| Analysis of the BioPlex automated RPR compared to traditional RPR
Titer differences between the BioPlex automated RPR compared to the traditional RPR were analyzed by testing additional serum samples that were reactive for the traditional RPR with the automated RPR for a total of 404 samples. When the titers for the traditional RPR reactive samples were compared to the titers for the automated RPR result, the correlation coefficient was 0.5294 ( Figure 2 ). The mean of the titer difference between the BioPlex RPR and the traditional RPR was 1.0 ± 0.9 titers. The concordance rate at ±2 titer and = or ±1 titer dilutions between the BioPlex RPR and the traditional RPR was 93.8% and 71.1%, respectively. In instances where the BioPlex RPR had a titer result >1:64 (n = 39) and a manual titer was performed, the ±2 titer and = or ±1 titer concordance rate was 94.9% and 64.1%, respectively.
The Bioplex automated RPR screen was compared to the traditional RPR as the gold standard for 457 samples that were tested by both assays, including all nonreactive RPR results ( Table 4) 
| D ISCUSS I ON
With the introduction of automated treponemal tests, a new reverse syphilis algorithm is now used by many clinical laboratories.
Our institution has been using the IgG BioPlex screen for our syphilis screening assay based on ease of use, high throughput, and automation. However, other syphilis screening assays, such as the LIASON T pallidum specific assay, however, detect both a As observed in our previous study, nearly all of the specimens with falsely reactive BioPlex syphilis screening results had very low AIs (range 0.9-1.7 AI), for both the IgG screen and the IgG/IgM screen. Many of the falsely reactive BioPlex results were from patients being screened for syphilis because of HIV infection, pretransplant workup or for prenatal screening for pregnancy. Pregnancy has been well recognized as a cause of false-reactive non-treponemal tests.
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The BioPlex automated RPR showed comparable results to the traditional RPR. And although manual dilutions were needed for specimens with a BioPlex RPR titer <1:4 and >1:64, the methods still compared well.
These findings are very similar to the results of the study by
Tesfazghi et al 12 which compared the BioPlex RPR to the Wampole Impact RPR card test and found 78% concordance within ±1 dilution and 94% concordance within ±2 dilutions.
At the time of their study, a prior offline dilution step was not supported on the BioPlex 2200. Our study was able to assess the BioPlex offline dilution step for RPR titers >1:64 and still found a good correlation between the traditional RPR method and the BioPlex RPR for titers >1:64 and for the 1:2 titers. The need for a manual offline dilution step for RPR titers >1:64 and titers of 1:2 should be pointed out as a limitation to the automated BioPlex RPR assay, as the assay is not actually 100% automated for high titer RPR results. 
